Literature DB >> 23399350

Cardiovascular risk factors in women who had hypertensive disorders late in pregnancy: a cohort study.

Wietske Hermes1, Arie Franx, Maria G van Pampus, Kitty W M Bloemenkamp, Michiel L Bots, Joris A van der Post, Martina Porath, Gabrielle A E Ponjee, Jouke T Tamsma, Ben Willem J Mol, Christianne J M de Groot.   

Abstract

OBJECTIVE: The purpose of this study was to determine cardiovascular risk factors in women with a history of hypertensive pregnancy disorders at term (HTP) 2.5 years after pregnancy. STUDY
DESIGN: In a multicenter cohort study in The Netherlands from June 2008 through November 2010, cardiovascular risk factors were compared between women with a history of HTP (HTP cohort, n = 306) and women with a history of normotensive pregnancies at term (NTP cohort, n = 99). HTP women had participated in a randomized, longitudinal trial assessing the effectiveness of induction of labor in women with hypertensive pregnancy disorders at term. All women were assessed 2.5 years after pregnancy for blood pressure, anthropometrics, glucose, glycosylated hemoglobin, insulin, homeostatic model assessment score, total cholesterol, high-density lipoprotein cholesterol, triglycerides, high-sensitivity C-reactive protein, and microalbumin and metabolic syndrome.
RESULTS: After a mean follow-up period of 2.5 years, hypertension (HTP, 34%; NTP, 1%; P < .001) and metabolic syndrome (HTP, 25%; NTP, 5%; P < .001) were more prevalent in HTP women compared with NTP women. HTP women had significantly higher systolic and diastolic blood pressure, higher body mass index, and higher waist circumference. Glucose, glycosylated hemoglobin, insulin, homeostatic model assessment score, total cholesterol, triglycerides, and high-sensitivity C-reactive protein levels were significantly higher and high-density lipoprotein cholesterol was significantly lower in HTP women.
CONCLUSION: In women with a history of HTP, hypertension and metabolic syndrome are more common, and they have higher levels of biochemical cardiovascular risk factors 2.5 years after pregnancy.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23399350     DOI: 10.1016/j.ajog.2013.02.016

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  33 in total

1.  The Relationship of Restless Legs Syndrome to History of Pregnancy-Induced Hypertension.

Authors:  Kim E Innes; Sahiti Kandati; Kathryn L Flack; Parul Agarwal; Terry Kit Selfe
Journal:  J Womens Health (Larchmt)       Date:  2016-02-25       Impact factor: 2.681

Review 2.  Adverse pregnancy outcomes and cardiovascular risk factor management.

Authors:  Puja K Mehta; Margo Minissian; C Noel Bairey Merz
Journal:  Semin Perinatol       Date:  2015-07-06       Impact factor: 3.300

3.  Intraabdominal fat, insulin sensitivity, and cardiovascular risk factors in postpartum women with a history of preeclampsia.

Authors:  Darcy R Barry; Kristina M Utzschneider; Jenny Tong; Kersten Gaba; Daniel F Leotta; John D Brunzell; Thomas R Easterling
Journal:  Am J Obstet Gynecol       Date:  2015-05-21       Impact factor: 8.661

Review 4.  Programming of maternal and offspring disease: impact of growth restriction, fetal sex and transmission across generations.

Authors:  Jean N Cheong; Mary E Wlodek; Karen M Moritz; James S M Cuffe
Journal:  J Physiol       Date:  2016-04-24       Impact factor: 5.182

Review 5.  Hypertensive Disorders of Pregnancy and Cardiovascular Diseases: Current Knowledge and Future Directions.

Authors:  Thais Coutinho; Olabimpe Lamai; Kara Nerenberg
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-06-19

6.  Cardiovascular biomarkers in the years following pregnancies complicated by hypertensive disorders or delivered preterm.

Authors:  Lauren J Tanz; Jennifer J Stuart; Stacey A Missmer; Eric B Rimm; Jennifer A Sumner; Mary A Vadnais; Janet W Rich-Edwards
Journal:  Pregnancy Hypertens       Date:  2018-04-18       Impact factor: 2.899

7.  Postpartum healthcare after gestational diabetes and hypertension.

Authors:  Deborah B Ehrenthal; Kristin Maiden; Stephanie Rogers; Amy Ball
Journal:  J Womens Health (Larchmt)       Date:  2014-08-04       Impact factor: 2.681

Review 8.  Importance of engaging obstetrician/gynecologists in cardiovascular disease prevention.

Authors:  Deborah B Ehrenthal; Janet M Catov
Journal:  Curr Opin Cardiol       Date:  2013-09       Impact factor: 2.161

Review 9.  Research Recommendations From the National Institutes of Health Workshop on Predicting, Preventing, and Treating Preeclampsia.

Authors:  Christine Maric-Bilkan; Vikki M Abrahams; S Sonia Arteaga; Ghada Bourjeily; Kirk P Conrad; Janet M Catov; Maged M Costantine; Brian Cox; Vesna Garovic; Eric M George; Alison D Gernand; Arun Jeyabalan; S Ananth Karumanchi; Aaron D Laposky; Menachem Miodovnik; Megan Mitchell; Victoria L Pemberton; Uma M Reddy; Mark K Santillan; Eleni Tsigas; Kent L R Thornburg; Kenneth Ward; Leslie Myatt; James M Roberts
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

10.  Adrenal, metabolic and cardio-renal dysfunction develops after pregnancy in rats born small or stressed by physiological measurements during pregnancy.

Authors:  Jean N Cheong; James S M Cuffe; Andrew J Jefferies; Karen M Moritz; Mary E Wlodek
Journal:  J Physiol       Date:  2016-06-12       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.